Article
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
4 Nov 2020
Abstract excerpt
Abstract The coronavirus SARS-CoV-2 is the cause of the ongoing COVID-19 pandemic. Therapeutic neutralizing antibodies constitute a key short-to-medium term approach to tackle COVID-19. However, traditional antibody production is hampered by long development times and costly production. Here, we report the rapid isolation and characterization of nanobodies from a synthetic library, known as sybodies (Sb), that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
